Rheumatology

Efficacy of Baricitinib in Patients with Moderate-To-Severe Rheumatoid Arthritis with 3 Years of Treatment: Results From a Long-term Study Abstract Objective To evaluate the long-term efficacy of once-daily baricitinib 4 mg in patients with active RA who were either naïve to DMARDs or who had inadequate response (IR) to MTX. Methods Read more…